via University of Waterloo
Researchers at the University of Waterloo are developing a DNA-based vaccine that can be delivered through a nasal spray.
The vaccine will work by using bacteriophage, a process that will allow the vaccine to replicate within bacteria already in the body and is being designed to target tissues in the nasal cavity and lower respiratory tract.
“When complete, our DNA-based vaccine will be administered non-invasively as a nasal spray that delivers nanomedicine engineered to immunize and decrease COVID-19 infections,” explains Roderick Slavcev, a professor in the School of Pharmacy who specializes in designing vaccines, pharmaceuticals and gene-therapy treatments. “This research combines the expertise of many and leverages existing technology developed by my team, which we’re reconfiguring for a COVID-19 application.”
When completed, the researchers aim to have the DNA-based vaccine enter cells in targeted tissues and cause them to produce a virus-like particle (VLP) that will stimulate an immune response in people.
The VLP will look similar to the structure of SARS-CoV-2 (the virus which causes COVID-19), but is harmless. This similarity will activate the body’s natural immune response to protect against viral infections comparable to the VLP, including SARS-CoV-2. It will also bind to receptors that SARS-CoV-2 would bind to, limiting the possible sites for transmission. By causing these changes in the body, the vaccine will build immunity against COVID-19 and decrease the severity of infections in progress – serving as both a therapeutic and a vaccine.
Every detail of the vaccine, from ensuring the bacteriophage target specific cells in the respiratory tract to creating a minimal VLP to impersonate SARS-CoV-2, is specifically engineered by the researchers and requires testing.
To achieve the design of such a complex project, Slavcev is teaming up with Emmanuel Ho, another professor at the School of Pharmacy, and Marc Aucoin, professor of chemical engineering. Ho’s team is designing the nanomedication that will be delivered by the nasal spray, which is currently being tested. Aucoin’s lab is constructing and purifying the VLP and boosting immunity following the initial administration of the therapeutic vaccine.
“It is the collaborative effort of our talented teams that makes this multidisciplinary project so feasible and necessarily efficient as a potential universal vaccine solution against SARS-CoV infections,” says Slavcev. “To practice science with such urgency alongside such talented colleagues and their students is not only immensely educational, it is extremely rewarding.”
Slavcev’s team has completed design of the bacteriophage delivery system and is currently modifying this system to apply to COVID-19. Additional design of components and further testing will take place later this year. Components of the research are supported by a grant from the Natural Sciences and Engineering Research Council of Canada.
Note: This research has not yet been peer-reviewed and is being released as part of UWaterloo’s commitment to help inform Canada’s COVID-19 response.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
DNA-based COVID-19 vaccine
- Approval to start trial of new Australian COVID-19 vaccineon April 12, 2021 at 8:53 pm
and we are looking forward to working with all our partners to bring and produce in Australia this COVID-19 DNA-based vaccine.” /Public Release. This material comes from the originating organization ...
- Zydus Cadila will seek emergency nod for its shot in June: CEO Patelon April 12, 2021 at 7:08 pm
Zydus does not expect the private market for the vaccine to open anytime soon. Zydus Cadila, which is developing a third generation DNA-based Covid-19 vaccine, expects to file for emergency approval ...
- Applied DNA CEO Discusses Relevance of DNA-based Cotton Traceability as Enabler of Ethical and Responsible Textile Manufacturing on BBC Business Dailyon April 8, 2021 at 11:00 am
Applied DNA CEO discusses relevance of DNA-based cotton traceability in textile manufacturing in interview with BBC.
- Applied DNA CEO Discusses Relevance of DNA-based Cotton Traceability as Enabler of Ethical and Responsible Textile Manufacturing on BBC Business Dailyon April 8, 2021 at 7:04 am
Applied DNA has also established a COVID-19 diagnostic and testing offering that is in the early stages of commercialization and is grounded in the Company’s deep expertise in DNA. The LinearDNA ...
- Families divided over COVID-19 misinformation from conflicting news sourceson April 5, 2021 at 6:52 pm
In responding to an ABC callout, readers said they often held opposing views about the COVID-19 pandemic to family members, and asked how to best handle disagreements at home.
Go deeper with Google Headlines on:
DNA-based COVID-19 vaccine
Go deeper with Bing News on:
- FDA, CDC Recommend ‘Pause’ For Johnson & Johnson COVID-19 Vaccine Over Clot Reportson April 13, 2021 at 8:14 pm
The U.S. is recommending a “pause” in using the single-dose Johnson & Johnson COVID-19 vaccine to investigate reports of potentially dangerous blood clots. Downtown Partnership Out With Annual ...
- Pfizer Expanding Production of COVID-19 Vaccine by 10%on April 13, 2021 at 6:22 pm
Get Report CEO says the company has ramped up production of its COVID-19 vaccine and can deliver 10% more doses to the U.S. than previously agreed by the end of May. CEO Albert Bourla said in a tweet ...
- Multiple Cubs coaches recommend COVID-19 vaccineon April 13, 2021 at 5:24 pm
Cubs coaches Craig Driver and Chris Young were partially vaccinated for COVID-19 when they tested positive for the virus, and according to Cubs manager David Ross, they recommend ...
- U.S. FDA to scrutinize vaccine design behind COVID-19 shots linked to blood clotson April 13, 2021 at 5:22 pm
CHICAGO/LONDON (Reuters) - With two COVID-19 vaccines now under scrutiny for possible links to very rare cases of blood clots in the brain, U.S. government scientists are focusing on whether the ...
- Australia returns to "war footing" amid COVID-19 vaccine turmoilon April 13, 2021 at 4:29 pm
Australia has fared much better than many other developed countries during the pandemic, with just over 29,400 COVID-19 cases and 910 deaths ... this week abandoned a target to provide at least one ...